FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental medicine, endocrinology and andrology. The method for treatment of adolescent hypogonadotropic hypogonadism in an experiment includes intramuscular administration of a 0.1% solution of kisspeptin Kiss 10 at a dose of 500 mcg for 7 days to 2-months old adolescent laboratory animals with hypogonadotropic hypogonadism simulated by surgical removal of one gonad in newborn male rats on days 1 to 3 of postnatal life.
EFFECT: invention ensures high efficiency of treatment of hypogonadism based on accurate and controlled experimental model of the pathology.
1 cl, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELLING MALE HYPOGONADOTROPIC HYPOGONADISM | 2020 |
|
RU2749477C1 |
| METHOD FOR PREDICTION OF REPRODUCTIVE DISORDERS IN BOYS WITH OBESITY | 2019 |
|
RU2706360C1 |
| METHOD FOR CORRECTION OF HYPOGONADISM IN ANIMALS DURING SIMULATION OF ACUTE INJURY OF SPINAL CORD | 2017 |
|
RU2689114C2 |
| METHOD FOR STIMULATING SPERMATOGENIC AND ANDROGEN-PRODUCING FUNCTIONS OF MALE GENITAL GLANDS | 1991 |
|
RU2040258C1 |
| METHOD OF TREATING HYPOGONADOTROPIC HYPOGONADISM, NASAL SPRAY AS METHOD FOR ADMINISTERING GONADORELIN ACETATE IN TREATING HYPOGONADOTROPIC HYPOGONADISM | 2019 |
|
RU2733465C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| METHOD OF PREDICTION OF CLINICAL EFFECTIVENESS OF TREATMENT WITH CHORIONIC GONADOTROPIN IN MALES WITH HYPOGONADISM | 2015 |
|
RU2604681C1 |
| METHOD OF TREATING SECONDARY HYPOGONADISM IN MALES | 1995 |
|
RU2117446C1 |
| METHOD FOR DIAGNOSING ORGANIC LESIONS OF THE CHIASMAL-SELLAR REGION IN PATIENTS WITH CENTRAL HYPOGONADISM | 2021 |
|
RU2777475C1 |
